DOCSLIB.ORG

CPT® New Codes 2019: Biopsy, Skin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CPT® New Codes 2019: Biopsy, Skin Billing and Coding Update Alexander Miller, M.D. AAD Representative to the AMA CPT Advisory Committee New Skin Biopsy CPT® Codes It’s all about the Technique! SPEAKER: Alexander Miller, M.D. AAD Representative to the AMA -CPT Advisory Committee Chair AAD Health Care Finance Committee Arriving on January 1, 2019 New and Restructured Biopsy Codes Tangential biopsy Punch Biopsy Incisional Biopsy How Did We Get Here? CMS CY 2016 Biopsy codes (11100, 11101 identified as potentially mis-valued; high expenditure RUC Survey sent to AAD Members Specialty survey results are the only tool available to support code values Challenging survey results Survey revealed bimodal data distribution; CPT Codes 11100, 11101 referred to CPT for respondents were valuing different procedures restructuring Rationale for New Codes 11100; 11101 • Previous skin biopsy codes did not distinguish between the different biopsy techniques that were being used CPT Recommended technique specification in new biopsy codes • Will also provide for reimbursement commensurate with the technique used How Did We Get Here? • CPT Editorial Panel deleted 11100; 11101 February 2017 • 6 New codes created based on technique utilized • Each technique: primary code and add-on code March 2017 • RUC survey sent to AAD members April 2017 • Survey results presented to the RUC Biopsy Codes Effective Jan., 1, 2019 • Integumentary biopsy codes 11755 Biopsy of nail unit (plate, bed, matrix, hyponychium, proximal and lateral nail folds 11100, 11101 have been deleted 30100 Biopsy, intranasal • New Skin Biopsy codes: 11102 - 40490 Biopsy of lip mucosa 11107 skin 40808 Biopsy, vestibule of mouth only, does not include mucosa 41100 Biopsy of tongue; anterior two-thirds 41105 Biopsy of tongue; posterior one-third • Site-specific biopsy codes still 41108 Biopsy of floor of mouth applicable 54100 Biopsy of penis 56605 Biopsy of vulva or perineum; 1 lesion 56606 Biopsy of vulva or perineum, each separate additional lesion All remain unchanged 67810 Incisional biopsy of eyelid skin including lid margin 69100 Biopsy external ear Definition: Procedure to obtain tissue solely for histopathologic examination • Sampling of a lesion You want to know what it is on histopathology, so you biopsy it • Stratum corneum sampling by any method (scraping, tape stripping) is not a biopsy Skin Biopsy codes can be reported to indicate: During excisions, destructions, or shave removals, that the procedure was tissue submitted performed independently, or that the procedure to obtain for histopathology was unrelated or distinct tissue was solely for is a routine from other diagnostic histopathologic component of such procedures/services examination; procedure(s) and is provided during the same not reported encounter separately biopsies performed on a different lesion or different site(s) on the same date of service may be reported separately as they are not considered components of other procedures Code Criterion is Based on Technique Optimal tissue Three distinct Biopsy sampling: consider techniques: technique type of neoplastic, three primary is selected inflammatory or other biopsy codes; based on: lesion requiring tissue three add-on diagnosis codes 2019 Skin Biopsy Codes 11102 11104 11106 Incisional Tangential biopsy Punch biopsy of biopsy of skin of skin, (eg, shave, skin, (including (eg, wedge), scoop, saucerize, simple closure (including simple curette), single when performed), closure when lesion single lesion performed), single lesion 11103 11105 11107 each separate/ each separate/ each separate/ additional lesion additional lesion additional lesion Tangential biopsy Vs. Shave removal TangentialTangential biopsybiopsy Shave removal • Intent: obtain tissue sample for • Intent: therapeutic removal of epidermal or epidermal-dermal lesion diagnostic pathologic examination • Instrument: removal with a sharp • Instrument: sharp blade, such as scalpel, blade, such as scalpel, flexible blade flexible blade, curette • Depth: not through dermis • Depth: may include epidermis only, or • No suturing required epidermis and dermis • Histopathologic tissue evaluation: may be done • Histopathologic tissue evaluation: always done • Code selection: determined by site and lesion size • Two codes only: primary and add-on Tangential biopsy vs. Shave removal, examples Tangential biopsy Shave removal • Biopsy of an inflammatory • Cosmetic shave removal of an dermatosis with the shave elevated nevus technique • Shave removal of irritated • Biopsy of a large atypical seborrheic keratosis, irritated pigmented lesion (saucerization or nevus scoop biopsy technique, into deep dermis) • Intent: to completely remove the lesion; or to completely remove • Intent: obtain an optimal tissue the noxious portion of lesion sample for histopathology Punch Biopsy (11104, 11105) Intent: Full-thickness removal of Manipulation of the a skin sample, including adjoining skin, such as obtain tissue sample for simple closure removal of adjacent diagnostic pathologic Punch penetrates standing cones/Burow’s examination using through dermis into triangles/dog ears is punch instrument subdermal space included Two codes only: Histopathologic tissue primary and add-on evaluation always done 11104 11105 Punch Biopsy Example Punch defect: Excision of Simple through dermis standing cones suturing included included Incisional Biopsy Vs. Excision Incisional Biopsy Excision, benign or malignant • Intent: obtain tissue sample for diagnostic • Intent: excision of entire lesion, with margins histopathologic examination • Instrument: sharp blade • Instrument: sharp blade (not a punch) • Depth: full-thickness, through dermis • Depth: full-thickness tissue sample: • Includes: simple closure o penetrates into the subcutaneous space • Histopathologic evaluation: usually done o May include large fat tissue sample, if • Code selection determined by: required (eg, panniculitis) – Benign vs. Malignant • Includes: simple closure – Location • Histopathologic evaluation: always done – Maximum excision diameter • Two codes only: primary and add-on Incisional Biopsy Vs. Soft Tissue Biopsy Incisional Biopsy Biopsy, Soft Tissue • Intent: obtain tissue sample for diagnostic • Intent: sampling of tissues deep to skin: histopathologic examination subcutaneous, subfascial, intramuscular • Instrument: sharp blade • Instrument: sharp blade (not a punch) • Tissue sample: subcutaneous or subfascial or • Tissue sample: full-thickness skin muscle o penetrates into the subcutaneous space o Skin may not be included • Includes: simple or intermediate repair o Contains skin • Histopathologic evaluation: always done o May include large fat tissue sample, if required • Code selection determined by: Location • Includes: simple closure o Type of biopsy: superficial or deep • Histopathologic evaluation: always done o • Two codes only: primary and add-on 2018 vs. 2019 Biopsy Coding 2018 2019 • First biopsy: • First biopsy: 11106: Incisional 11100 11104: Punch each additional: 11101 11102: Tangential each additional: 11107: Incisional 11105: Punch 11103: Tangential Biopsy Coding Hierarchies Incisional Punch Biopsy Tangential biopsy 11106 11104 Biopsy 11102 Additional Additional incisional: punch: Additional 11107 11105 tangential: 11103 Additional Additional Punch: 11105 tangential: Additional 11103 tangential: 11103 Single Technique Biopsy Coding Examples Tangential Punch Incisional Three tangential Bx: Three punch Bx: Two incisional Bx: 11102, 11103x2 11104, 11105x2 11106, 11107 Multiple Biopsies, Different Lesions or Sites More than one biopsy List the highest value Additional biopsy add- with different base (primary) code on codes in order of techniques used for first highest to lowest value each additional lesion 11102 +11103 3 11104 +11105 2 11106 1 +11107 Multiple Biopsies of Different Lesions or Sites • Only one primary code is used, regardless if multiple biopsy techniques used • When multiple biopsies are done, use one primary code and add- on code(s) appropriate to the additional biopsy techniques used • Incisional biopsy (11106) is always primary to other biopsy techniques • Punch biopsy (11104) is always primary when shave biopsy also performed Multiple Techniques Biopsy Coding Examples One incisional, Two punch, one One incisional, one punch, two tangential two tangential tangential • 11106 • 11104 (punch) • 11106 (incisional) (incisional) • 11105 (punch) • 11105 (punch) • 11103 • 11103 (tangential) • 11103x2 (tangential) (tangential) • 11103 (tangential) CMS 2019 Proposed RVUs Code Descriptor RVU 11102 Tangential .66 11103 Tangential Add-On .29 (RUC recommended .38) 11104 Punch .83 11105 Punch Add-On .45 11106 Incisional 1.01 11107 Incisional Add-On .54 11100 Deleted Biopsy .81 11101 Deleted Biopsy Add-On .41 CMS Proposed Values for Skin Biopsy Codes - 2019 Medicare Medicare 2018 National National Total 2019 Total Average Average 2019 2018 2019 Non- Non- 2018 2019 CPT®/ Work Work Facility Facility Payment Payment HCPCS Description RVUs RVUs RVUs RVUs Amount $ Amount $ 11100 Biopsy of skin 0.81 n/a 3.00 NA $108.00 NA 11101 Biopsy of skin add-on 0.41 n/a 0.93 NA $33.48 NA 11102 Tangential bx skin single lesion NA 0.66 NA 2.68 NA $96.60 11103 Tangential bx skin ea sep/addl NA 0.29 NA 0.64 NA $23.07 11104 Punch bx skin single lesion NA 0.83 NA 3.37 NA $121.48 11105 Punch bx skin ea sep/addl NA 0.45 NA 1.09 NA $39.29 11106 Incisional bx skin single lesion NA 1.01 NA 4.06 NA $146.35 11107 Incisional bx skin ea sep/addl NA 0.54 NA 1.25 NA $45.06 National Correct Coding Edits • Medically
Load more

Recommended publications
  • ANMC Specialty Clinic Services
    Cardiology Dermatology Diabetes Endocrinology Ear, Nose and Throat (ENT) Gastroenterology General Medicine General Surgery HIV/Early Intervention Services Infectious Disease Liver Clinic Neurology Neurosurgery/Comprehensive Pain Management Oncology Ophthalmology Orthopedics Orthopedics – Back and Spine Podiatry Pulmonology Rheumatology Urology Cardiology • Cardiology • Adult transthoracic echocardiography • Ambulatory electrocardiology monitor interpretation • Cardioversion, electrical, elective • Central line placement and venous angiography • ECG interpretation, including signal average ECG • Infusion and management of Gp IIb/IIIa agents and thrombolytic agents and antithrombotic agents • Insertion and management of central venous catheters, pulmonary artery catheters, and arterial lines • Insertion and management of automatic implantable cardiac defibrillators • Insertion of permanent pacemaker, including single/dual chamber and biventricular • Interpretation of results of noninvasive testing relevant to arrhythmia diagnoses and treatment • Hemodynamic monitoring with balloon flotation devices • Non-invasive hemodynamic monitoring • Perform history and physical exam • Pericardiocentesis • Placement of temporary transvenous pacemaker • Pacemaker programming/reprogramming and interrogation • Stress echocardiography (exercise and pharmacologic stress) • Tilt table testing • Transcutaneous external pacemaker placement • Transthoracic 2D echocardiography, Doppler, and color flow Dermatology • Chemical face peels • Cryosurgery • Diagnosis
    [Show full text]
  • A Clinical and Histological Study of Radiofrequency-Assisted Liposuction (RFAL) Mediated Skin Tightening and Cellulite Improvement ——RFAL for Skin Tightening
    Journal of Cosmetics, Dermatological Sciences and Applications, 2011, 1, 36-42 doi:10.4236/jcdsa.2011.12006 Published Online June 2011 (http://www.SciRP.org/journal/jcdsa) A Clinical and Histological Study of Radiofrequency-Assisted Liposuction (RFAL) Mediated Skin Tightening and Cellulite Improvement ——RFAL for Skin Tightening Marc Divaris1, Sylvie Boisnic2, Marie-Christine Branchet2, Malcolm D. Paul3 1Plastic and Maxillo-Facial Surgery, University of Pitie Salpetiere, Paris, France; 2Institution GREDECO, Paris, France; 3Department of Surgery, Aesthetic and PlasticSurgery Institute, University of California, Irvine, USA. Email: [email protected] Received May 1st, 2011; revised May 27th, 2011; accepted June 6th, 2011. ABSTRACT Background: A novel Radiofrequency-Assisted Liposuction (RFAL) technology was evaluated clinically. Parallel origi- nal histological studies were conducted to substantiate the technology’s efficacy in skin tightening, and cellulite im- provement. Methods: BodyTiteTM system, utilizing the RFAL technology, was used for treating patients on abdomen, hips, flanks and arms. Clinical results were measured on 53 patients up to 6 months follow-up. Histological and bio- chemical studies were conducted on 10 donors by using a unique GREDECO model of skin fragments cultured under survival conditions. Fragments from RFAL treated and control areas were examined immediately and after 10 days in culture, representing long-term results. Skin fragments from patients with cellulite were also examined. Results: Grad- ual improvement in circumference reduction (3.9 - 4.9 cm) and linear contraction (8% - 38%) was observed until the third month. These results stabilized at 6 months. No adverse events were recorded. Results were graded as excellent by most patients, including the satisfaction from minimal pain, bleeding, and downtime.
    [Show full text]
  • Co™™I™™Ee Opinion
    The American College of Obstetricians and Gynecologists WOMEN’S HEALTH CARE PHYSICIANS COMMITTEE OPINION Number 673 • September 2016 (Replaces Committee Opinion No. 345, October 2006) Committee on Gynecologic Practice This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice and the American Society for Colposcopy and Cervical Pathology (ASCCP) in collaboration with committee member Ngozi Wexler, MD, MPH, and ASCCP members and experts Hope K. Haefner, MD, Herschel W. Lawson, MD, and Colleen K. Stockdale, MD, MS. This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Persistent Vulvar Pain ABSTRACT: Persistent vulvar pain is a complex disorder that frequently is frustrating to the patient and the clinician. It can be difficult to treat and rapid resolution is unusual, even with appropriate therapy. Vulvar pain can be caused by a specific disorder or it can be idiopathic. Idiopathic vulvar pain is classified as vulvodynia. Although optimal treatment remains unclear, consider an individualized, multidisciplinary approach to address all physical and emotional aspects possibly attributable to vulvodynia. Specialists who may need to be involved include sexual counselors, clinical psychologists, physical therapists, and pain specialists. Patients may perceive this approach to mean the practitioner does not believe their pain is “real”; thus, it is important to begin any treatment approach with a detailed discussion, including an explanation of the diagnosis and determination of realistic treatment goals. Future research should aim at evaluating a multimodal approach in the treatment of vulvodynia, along with more research on the etiologies of vulvodynia.
    [Show full text]
  • Mohs Surgery Educational Information for Patients
    DEPARTMENT OF DERMATOLOGY Mohs Surgery Educational information for patients Thank you for choosing the OHSU Department of Dermatology to provide your dermatologic care. Since the 1920s, the Department of Dermatology has been educati ng doctors, researching skin diseases and providing world-class care to pati ents in Oregon and beyond. We thank you for trusti ng us with your care. The surgeons and staff within the department welcome you. We have prepared this educati onal informati on to answer the most common questi ons presented to us by our pati ents. If you have additi onal questi ons aft er reading this material, please let us know. Some of the questi ons addressed include: • What is skin cancer? • What is Mohs surgery? • How do I prepare for Mohs surgery? • What happens the day of surgery? • What type of wound will I have and how will I care for that wound aft er surgery? • What measures can I take to prevent future skin cancer? What is skin cancer? Cancer is the abnormal growth of cells at an uncontrolled and unpredictable rate. The cancer tissue usually grows at the expense of surrounding normal tissue. The abnormal growth (cancer) originates in the uppermost layer of the skin and may grow downward, forming root and fi nger-like projections under the surface of the skin. Unfortunately, these roots may be subtle and unable to be seen without the aid of a microscope. Therefore, what you see on your skin is sometimes only a small portion of the total cancer. The most common types of skin cancer are basal cell carcinoma and squamous cell carcinoma.
    [Show full text]
  • MOHS SURGERY INFORMATION SHEET Greg S
    1 California Skin Institute MOHS SURGERY INFORMATION SHEET Greg S. Morganroth, MD Brian Somoano, MD Joanna Chan, MD www.CAskin.com 525 South Drive, Suite 115 Ph: (650) 969-5600 2420 Samaritan Drive Ph: (408) 369-5600 Mountain View, California 94040 Fax: (650) 969-0360 San Jose, CA 95124 Fax: (408) 558-7949 PLEASE NOTE: THIS INFORMATION SHEET; A REGISTRATION FORM FOR NEW PATIENTS; BEFORE AND AFTER PHOTOS OF ADVANCED FACIAL RECONSTRUCTION; AND ADDITIONAL RESOURCES CAN BE FOUND AT: www.CAskin.com. You are waiting to undergo an advanced skin cancer removal procedure called Mohs Micrographic Surgery. The origin of this technique dates back to the 1930’s when Dr. Frederick Mohs at The University of Wisconsin was researching a way to remove complicated skin cancers unresponsive to traditional therapies such as standard excisional surgery, cryosurgery (freezing), electrodessication and curettage (scraping and burning), and radiation therapy. In the 21st Century, Mohs Micrographic Surgery represents the state-of-the-art treatment for skin cancer by providing the highest cure rate, minimal sacrifice of normal skin, and smallest possible scar. The American College of Mohs Micrographic Surgery and Cutaneous Oncology (www.mohscollege.org) is the official organization responsible for training Mohs surgeons and maintaining the standard-of-care in the specialty of Mohs Surgery. To become a member of this organization and be known as a Mohs surgeon, a special one to two-year fellowship following a dermatology residency is required. Only a limited number of dermatologists are trained each year to be Mohs surgeons to maintain the highest level of competence in the specialty.
    [Show full text]
  • MOHS SURGERY and RECONSTRUCTION a Handbook for Patients
    MOHS AND DERMATOLOGIC SURGERY CENTER MOHS SURGERY AND RECONSTRUCTION A Handbook for Patients Focused on cancer. Focused on life. Table of Contents Introduction.....................................................................................................2 Skin Cancer Types............................................................................................3 Causes of Skin Cancer......................................................................................4 Growth of Skin Cancer ....................................................................................4 Skin Cancer Treatment ....................................................................................4 Mohs Surgery ...................................................................................................5 Steps in Mohs Surgery......................................................................................5 Duration of Mohs Surgery ...............................................................................7 Effectiveness of Mohs Surgery ..........................................................................7 Advantages of Mohs Surgery ............................................................................7 Reconstruction of the Surgical Wound.............................................................8 Pre-Operative Instructions................................................................................9 Pre-Operative Medications ...............................................................................9 Healing
    [Show full text]
  • A Practical Guide to Frozen Section Technique Stephen R
    A Practical Guide to Frozen Section Technique Stephen R. Peters Editor A Practical Guide to Frozen Section Technique Editor Stephen R. Peters University of Medicine and Dentistry of New Jersey New Jersey Medical School Newark, NJ USA [email protected] ISBN 978-1-4419-1233-6 e-ISBN 978-1-4419-1234-3 DOI 10.1007/978-1-4419-1234-3 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2009933112 © Springer Science+Business Media, LLC 2010 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) Preface Frozen section technique is a valuable tool used to rapidly prepare slides from tis- sue for microscopic interpretation. Frozen section technique is used in a myriad of clinical and research settings. In surgical pathology, frozen sections are routinely used for rapid intra-operative diagnosis, providing guidance for our surgical col- leagues.
    [Show full text]
  • Mohs Micrographic Surgery: Current Techniques Ofer Arnon MD1, Ronald P
    IMAJ • VOL 12 • JuLy 2010 REVIEWS Mohs Micrographic Surgery: Current Techniques Ofer Arnon MD1, Ronald P. Rapini MD2, Adam J. Mamelak MD3 and Leonard H. Goldberg MD4 1Department of Plastic and Reconstructive Surgery, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel 2Departments of Dermatology and Pathology, University of Texas Medical School and MD Anderson Cancer Center, Houston, TX, USA 3Department of Dermatology, The Methodist Hospital, Houston, TX, USA 4DermSurgery Associates, Houston, TX, USA evaluation. The “horizontal” sectioning allowed for complete KEY WORDS: Mohs micrographic surgery, frozen sections, skin tumors, examination of the peripheral tumor margin. Since then, his tissue conservation, histologically clear margins technique has continued to evolve. It has become the gold IMAJ 2010; 12: 431–435 standard and has found a secure niche in the management of cutaneous malignancies. CUTANEOUS MALIGNANCY For Editorial see page 441 Several modalities are used for the treatment of skin cancers, ohs micrographic surgery is considered the most con- including curettage and electrodessication, laser, cryotherapy, M servative yet reliable approach to the management of radiation therapy, topical or intralesional drug therapy, con- cutaneous malignancies. The concept of MMS is simple, ventional excision, and MMS. Laser, cryotherapy and radiol- but its technique, which involves a series of suboperations, ogy are destructive procedures that rely on clinical and often is complex. Although many refinements have been made visual assessment of the tumor’s extent but lack pathologic to the original Mohs technique, the main objectives are the verification of clear margins. ED&C does not permit margin same.
    [Show full text]
  • Mohs Micrographic Surgery FACT SHEET
    IMPORTANT REMINDERS FOR YOUR MOHS SURGERY 9/15/11 DO advise us as soon as possible if you must cancel or change your appointment. If you have a bad cold, the flu, or a fever greater than 100˚, the day prior to your surgery, call the office 731-784-4300. It may be necessary to reschedule your appointment. DO get a good night’s sleep prior to surgery. DO take your usual medications on schedule unless instructed otherwise. DO eat a good breakfast, and consider bringing snacks or a light lunch. DO dress comfortably with a button up shirt or blouse if your surgery is on the chest or back. Avoid wearing an undershirt which must be pulled over the head. DO bathe & shampoo your hair the night prior to surgery (the surgery site must be kept absolutely dry for at least 24 hours after surgery). DO bring something to occupy your time for the waiting periods, WIFI is available in the clinic. DO let us know on the medical history form if you are taking aspirin or products containing aspirin under the direction of a physician. DO BRING A DRIVER. DRIVING CAN BE HAZARDOUS AND IS STRONGLY DISCOURAGED IF WE ARE WORKIONG AROUND YOUR EYES. DO have plain Tylenol on hand at home, and bring some with you, to take before your local anesthesia wears off. You should plan to take some 3x a day for the first 3 days. DO have ice packs at home (a freezer bag of frozen peas or corn kernels works well). DO NOT stop your blood thinner such as Plavix, Coumadin, or aspirin if prescribed by a doctor.
    [Show full text]
  • Slide Courtesy of Jeff North, MD
    3/17/2017 Basic Dermatology Procedures Basic Dermatology Procedures for the Non‐dermatologist • Liquid Nitrogen • Skin Biopsies Lindy P. Fox, MD • Electrocautery Associate Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco [email protected] I have no conflicts of interest to disclose 1 Liquid Nitrogen Cryosurgery 1 3/17/2017 Liquid Nitrogen Cryosurgery Liquid Nitrogen Cryosurgery Principles • Indications • ‐ 196°C (−320.8°F) – Benign, premalignant, in situ malignant lesions • Temperatures of −25°C to −50°C (−13°F to −58°F) within 30 seconds with spray or probe • Objective – Selective tissue necrosis • Benign lesions: −20°C to −30°C (−4°F to −22°F) • Reactions predictable • Malignant lesions: −40°C to −50°C. – Crust, bulla, exudate, edema, sloughing • Post procedure hypopigmentation • Rapid cooling intracellular ice crystals • Slow thawing tissue damage – Melanocytes are more sensitive to freezing than • Duration of THAW (not freeze) time is most keratinocytes important factor in determining success Am Fam Physician. 2004 May 15;69(10):2365‐2372 Liquid Nitrogen Cryosurgery • Fast freeze, slow thaw cycles – Times vary per condition (longer for deeper lesion) – One cycle for benign, premalignant – Two cycles for warts, malignant (not commonly done) • Lateral spread of freeze (indicates depth of freeze) – Benign lesions 1‐2mm beyond margins – Actinic keratoses‐ 2‐3mm beyond margins – Malignant‐ 3‐5+mm beyond margins (not commonly done) From: Bolognia, Jorizzo, and Schaffer.
    [Show full text]
  • SKIN GRAFTS and SKIN SUBSTITUTES James F Thornton MD
    SKIN GRAFTS AND SKIN SUBSTITUTES James F Thornton MD HISTORY OF SKIN GRAFTS ANATOMY Ratner1 and Hauben and colleagues2 give excel- The character of the skin varies greatly among lent overviews of the history of skin grafting. The individuals, and within each person it varies with following highlights are excerpted from these two age, sun exposure, and area of the body. For the sources. first decade of life the skin is quite thin, but from Grafting of skin originated among the tilemaker age 10 to 35 it thickens progressively. At some caste in India approximately 3000 years ago.1 A point during the fourth decade the thickening stops common practice then was to punish a thief or and the skin once again begins to decrease in sub- adulterer by amputating the nose, and surgeons of stance. From that time until the person dies there is their day took free grafts from the gluteal area to gradual thinning of dermis, decreased skin elastic- repair the deformity. From this modest beginning, ity, and progressive loss of sebaceous gland con- skin grafting evolved into one of the basic clinical tent. tools in plastic surgery. The skin also varies greatly with body area. Skin In 1804 an Italian surgeon named Boronio suc- from the eyelid, postauricular and supraclavicular cessfully autografted a full-thickness skin graft on a areas, medial thigh, and upper extremity is thin, sheep. Sir Astley Cooper grafted a full-thickness whereas skin from the back, buttocks, palms of the piece of skin from a man’s amputated thumb onto hands and soles of the feet is much thicker.
    [Show full text]
  • Revised Mohs Surgery Care Guidelines for Squamous Cell Carcinoma In-Situ Are Overdue
    Volume 25 Number 3| March 2019| Dermatology Online Journal || Commentary 25(3):2 Revised Mohs surgery care guidelines for squamous cell carcinoma in-situ are overdue Sama K Carley1 MD, Anthony Dixon2 PhD MBBS, Christopher B Zachary1 MBBS FRCP, Howard K Steinman3,4 MD Affiliations: 1University of California Irvine, Department of Dermatology, Irvine, California, USA, 2Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia, 3Campbell University School of Osteopathic Medicine, Lillington, NC, USA, 4US Dermatology Partners, Grapevine, Texas, USA Corresponding Author: Christopher B. Zachary MBBS FRCP, University of California, Irvine, Department of Dermatology, 118 Med Surge I, Irvine, California 92697, Tel: 949-824-4405, Email: [email protected] Surgery Appropriate Use Criteria (MAUC), [1]. We Abstract discuss the rationale for a change in the MAUC for The treatment of cutaneous squamous cell SCCis. carcinoma in situ by Mohs micrographic surgery is currently deemed as appropriate by the Mohs Discussion Appropriate Use Criteria. However, squamous cell carcinoma in situ is a very superficial, indolent, low- Cutaneous SCCis is a common, intra-epidermal, low- risk tumor amenable to destructive and non-surgical risk, indolent malignancy [2, 3]. Many involve the treatments. It is uncommon for squamous cell superficial hair follicle [4]. However, risk of progression carcinoma in situ to have progressed to invasive to invasive SCC is only 3-5%, and SCCis has a negligible malignancy subsequent to definitive management. risk of metastasis [5, 6]. This low risk of progression to The suggestion that squamous cell carcinoma in situ SCC and metastasis exists despite the reported on certain anatomic locations has a poorer prognosis presence of invasive SCC in 9.8% of biopsies diagnosed is widely assumed but lacks an evidence base.
    [Show full text]